Glucose Health Statistics
Total Valuation
Glucose Health has a market cap or net worth of $8.50 million. The enterprise value is $8.30 million.
Market Cap | 8.50M |
Enterprise Value | 8.30M |
Important Dates
The last earnings date was Wednesday, February 8, 2023.
Earnings Date | Feb 8, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
Glucose Health has 17.01 million shares outstanding. The number of shares has increased by 10.40% in one year.
Shares Outstanding | 17.01M |
Shares Change (YoY) | +10.40% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 5.11% |
Owned by Institutions (%) | n/a |
Float | 8.27M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 15.89 |
Forward PS | n/a |
PB Ratio | 32.98 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 15.51 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.80, with zero debt.
Current Ratio | 2.80 |
Quick Ratio | 1.58 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -163.72% and return on invested capital (ROIC) is -163.72%.
Return on Equity (ROE) | -163.72% |
Return on Assets (ROA) | -105.81% |
Return on Capital (ROIC) | -163.72% |
Revenue Per Employee | $178,241 |
Profits Per Employee | -$140,651 |
Employee Count | 3 |
Asset Turnover | 1.48 |
Inventory Turnover | 1.34 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.30% in the last 52 weeks. The beta is 3.48, so Glucose Health's price volatility has been higher than the market average.
Beta (1Y) | 3.48 |
52-Week Price Change | +6.30% |
50-Day Moving Average | 0.69 |
200-Day Moving Average | 0.37 |
Relative Strength Index (RSI) | 41.03 |
Average Volume (30 Days) | 22,608 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Glucose Health had revenue of $534,724 and -$421,953 in losses. Loss per share was -$0.02.
Revenue | 534,724 |
Gross Profit | 215,752 |
Operating Income | -421,950 |
Pretax Income | -421,953 |
Net Income | -421,953 |
EBITDA | -421,950 |
EBIT | n/a |
Loss Per Share | -$0.02 |
Balance Sheet
The company has $203,879 in cash and no debt, giving a net cash position of $203,879 or $0.01 per share.
Cash & Cash Equivalents | 203,879 |
Total Debt | n/a |
Net Cash | 203,879 |
Net Cash Per Share | $0.01 |
Equity / Book Value | 257,724 |
Book Value Per Share | 0.02 |
Working Capital | 254,429 |
Cash Flow
Operating Cash Flow | -241,576 |
Capital Expenditures | n/a |
Free Cash Flow | -241,576 |
FCF Per Share | -$0.01 |
Margins
Gross margin is 40.35%, with operating and profit margins of -78.91% and -78.91%.
Gross Margin | 40.35% |
Operating Margin | -78.91% |
Pretax Margin | -78.91% |
Profit Margin | -78.91% |
EBITDA Margin | -78.91% |
EBIT Margin | n/a |
FCF Margin | -45.18% |
Dividends & Yields
Glucose Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.40% |
Shareholder Yield | -10.40% |
Earnings Yield | -4.96% |
FCF Yield | -2.84% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 17, 2014. It was a reverse split with a ratio of 1:50.
Last Split Date | Nov 17, 2014 |
Split Type | Reverse |
Split Ratio | 1:50 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |